Bessemer Group Inc. Has $1.79 Million Stock Holdings in Waters Corporation $WAT

Bessemer Group Inc. boosted its holdings in Waters Corporation (NYSE:WAT) by 76.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 6,002 shares of the medical instruments supplier’s stock after acquiring an additional 2,603 shares during the period. Bessemer Group Inc.’s holdings in Waters were worth $1,788,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently modified their holdings of the stock. Zions Bancorporation National Association UT grew its position in Waters by 121.2% in the fourth quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 40 shares during the last quarter. SHP Wealth Management bought a new stake in Waters during the 4th quarter worth approximately $32,000. DV Equities LLC bought a new stake in Waters during the 4th quarter worth approximately $32,000. Anchor Investment Management LLC acquired a new position in Waters in the 1st quarter valued at approximately $27,000. Finally, Louisbourg Investments Inc. bought a new position in shares of Waters during the first quarter valued at $30,000. 94.01% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on the company. JPMorgan Chase & Co. increased their price objective on Waters from $330.00 to $345.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. The Goldman Sachs Group upped their price target on Waters from $380.00 to $425.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Wolfe Research initiated coverage on Waters in a research note on Tuesday, June 2nd. They issued an “outperform” rating and a $425.00 price target for the company. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $350.00 price objective on shares of Waters in a research note on Thursday, May 7th. Finally, Evercore reiterated an “outperform” rating and issued a $410.00 target price on shares of Waters in a report on Monday, July 6th. Three equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $401.60.

Waters Stock Performance

Shares of Waters stock opened at $370.93 on Thursday. The business has a 50-day moving average price of $363.34 and a two-hundred day moving average price of $345.93. Waters Corporation has a 1-year low of $275.05 and a 1-year high of $414.15. The company has a current ratio of 1.79, a quick ratio of 1.13 and a debt-to-equity ratio of 0.32. The company has a market cap of $36.42 billion, a P/E ratio of 47.13, a PEG ratio of 2.22 and a beta of 1.20.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.31 by $0.39. Waters had a return on equity of 15.60% and a net margin of 11.91%.The company had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.20 billion. During the same period in the previous year, the business earned $2.25 EPS. The firm’s revenue was up 91.4% compared to the same quarter last year. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. As a group, analysts anticipate that Waters Corporation will post 14.51 EPS for the current year.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.